Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, and OncoSec Medical Incorporated (“OncoSec”) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, are pleased to announce they
Motif Bio® plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that the Company has filed a “universal” shelf registration statement on Form F-3 with
Matra Petroleum AB (NASDAQ:MATRA) is a Swedish independent oil and gas exploration and production company operating in the United States. With proven reserves of 22.9 million barrels of oil equivalent
Motif Bio plc (AIM/NASDAQ: MTFB), a clinical stage biopharmaceutical company specialising in developing novel antibiotics, announced today that the US Food and Drug Administration (“FDA”) has granted its investigational drug
Shire plc (LSE:SHP, NASDAQ:SHPG) announces that the Marketing Authorization Application (MAA) for Lifitegrast, submitted on 07 August 2017, has been validated by the UK as the Reference Member State involved
Tesla expects to raise nearly $1.8bn (£1.4bn) by selling “junk” bonds to private investors – even more than the electric car-maker aimed for when it announced the offering this month.
Despite retail sales soaring past £7 billion, Amazon UK (NASDAQ:AMZN) only paid £7.4 million in tax last year, 50 percent less than the year previous.
Investors know the NYSE as a home for the world’s most important blue chip stocks. Massive companies like Walmart, Berkshire Hathaway, Exxon Mobil, and Coca-Cola are listed on the exchange
and then